(8S,9S,13S,14S)-17-(5-chloropyridin-3-yl)-2-methoxy-13-methyl-7,8,9,11,12,13,14,15-octahydro-6H-cyclopenta[a]phenanthren-3-yl sulfamate

ID: ALA5197695

PubChem CID: 168288190

Max Phase: Preclinical

Molecular Formula: C24H27ClN2O4S

Molecular Weight: 475.01

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc2c(cc1OS(N)(=O)=O)CC[C@@H]1[C@@H]2CC[C@]2(C)C(c3cncc(Cl)c3)=CC[C@@H]12

Standard InChI:  InChI=1S/C24H27ClN2O4S/c1-24-8-7-17-18(21(24)6-5-20(24)15-9-16(25)13-27-12-15)4-3-14-10-23(31-32(26,28)29)22(30-2)11-19(14)17/h5,9-13,17-18,21H,3-4,6-8H2,1-2H3,(H2,26,28,29)/t17-,18+,21-,24+/m0/s1

Standard InChI Key:  MXBQNUZERUFITR-OPNQQPSUSA-N

Molfile:  

 
     RDKit          2D

 35 39  0  0  0  0  0  0  0  0999 V2000
   -2.1164   -1.3218    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4019   -0.9093    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6876   -1.3218    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6876   -2.1468    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4019   -2.5593    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1164   -2.1468    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0268   -0.9094    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7412   -1.3219    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7412   -2.1468    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0268   -2.5593    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0268   -0.0843    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7413    0.3280    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4557   -0.0844    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4557   -0.9094    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2402   -1.1642    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2403    0.1704    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7250   -0.4970    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4539    0.9675    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4557    0.7407    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8311   -2.5593    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.7412   -0.4966    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    0.0268   -1.7345    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    1.4557   -1.7346    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    1.8705    1.5512    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0842    2.3457    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.8814    2.5593    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4633    1.9798    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2544    1.1820    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2604    2.1934    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -2.8311   -0.9092    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8311   -0.0840    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5457   -2.1468    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2604   -2.5593    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1323   -1.4308    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9583   -1.4308    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  3  2  1  0
  4  3  2  0
  5  4  1  0
  1  6  1  0
  6  5  2  0
  3  7  1  0
  8  7  1  0
  9  8  1  0
 10  9  1  0
  4 10  1  0
  7 11  1  0
 12 11  1  0
 13 12  1  0
 14 13  1  0
  8 14  1  0
 14 15  1  0
 13 16  1  0
 16 17  2  0
 17 15  1  0
 16 18  1  0
 13 19  1  1
  6 20  1  0
  8 21  1  1
  7 22  1  6
 14 23  1  6
 24 18  2  0
 25 24  1  0
 26 25  2  0
 27 26  1  0
 28 27  2  0
 18 28  1  0
 27 29  1  0
  1 30  1  0
 30 31  1  0
 20 32  1  0
 32 33  1  0
 32 34  2  0
 32 35  2  0
M  END

Alternative Forms

  1. Parent:

    ALA5197695

    ---

Associated Targets(Human)

CCRF-CEM (65223 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HeLa (62764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HMEC-1 (426 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Tubulin (1327 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Vero (26788 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 475.01Molecular Weight (Monoisotopic): 474.1380AlogP: 4.88#Rotatable Bonds: 4
Polar Surface Area: 91.51Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 10.50CX Basic pKa: 3.00CX LogP: 4.31CX LogD: 4.31
Aromatic Rings: 2Heavy Atoms: 32QED Weighted: 0.68Np Likeness Score: 0.82

References

1. Huo H, Li G, Shi B, Li J..  (2022)  Recent advances on synthesis and biological activities of C-17 aza-heterocycle derived steroids.,  69  [PMID:35749841] [10.1016/j.bmc.2022.116882]

Source